IRB Advisor – June 1, 2009
June 1, 2009
View Issues
-
Challenging conventional wisdom that IRBs delay clinical trials
The conventional wisdom in research circles is that IRBs are the main drag on the process, slowing down the progress of a clinical trial with an unnecessarily complicated review system. -
Helping break the logjam: What IRBs can do
In trying to streamline the IRB process, institutions should look to other industries as an example, says David Dilts, PhD, director of the Center for Management Research in Healthcare at Vanderbilt University in Nashville, TN. -
Pfizer sets standard to require IRB accreditation
A major pharmaceutical company is leading the way to making accreditation as ubiquitous among IRBs as it is among health care organizations. -
Many IRBs may not know member interest conflicts
A significant minority of IRBs at some of the nation's biggest medical institutions lack sufficient procedures to determine when IRB members have industry relationships that could pose a conflict in their work. -
Tight ship: CAPTN enlists IRB oversight
When they set out to create a research network to conduct clinical trials in the psychiatric care of children and adolescents, researchers at Duke University's Clinical Research Institute (DCRI) knew IRB issues would play a major role. -
Software Solutions: Electronic IRB submission integrated for easier use
Electronic IRB submission technology can be of great use to even small research institutions, once it's integrated with existing technology. -
Nurture young scientists, invite them to join the IRB
IRBs often seek new members who are experienced scientists, professors, and medical doctors. But they might be missing an opportunity to educate and engage young scientists by overlooking that pool of potential ethics board members. -
PhD research assistants help PIs complete IRB submission forms
The University of Louisville in Louisville, KY, has developed a program that serves as a dual-purpose human subjects research educational program, helping both doctoral students and experienced research professors and others. -
News Brief: Accredited IRBs fare better during FDA inspections
The Association for the Accreditation of Human Research Projection Programs (AAHRPP) of Washington, DC, has found in an ongoing study that federal investigators find fewer problems in studies conducted at AAHRPP-accredited organizations.